"Your digestion has always been unpredictable. But lately it's following a pattern."
Bloating that arrives two days before your period. Constipation in the luteal phase, then urgency in the follicular. Cramping that overlaps with low-energy days but doesn't feel cycle-related. If any of this sounds familiar, you're not imagining it — and you're not alone.
Research suggests that up to 42% of women with PCOS/PMOS also meet criteria for irritable bowel syndrome. But almost nothing in the standard IBS literature acknowledges the hormonal driver. Most IBS treatment protocols are designed for people without cyclical hormone fluctuation. That's a significant gap when your gut is, in large part, a hormone-sensing organ.
This is what your Atlas check-in data is positioned to reveal — the gut-hormone patterns that sit beneath a diagnosis that tells you "it's IBS" without telling you why it's worse some weeks than others.
The shared biology: why PCOS/PMOS and IBS overlap
Four mechanisms explain why these two conditions co-occur at rates far above chance:
1. Oestrogen and gut motility
Oestrogen receptors are distributed throughout the gastrointestinal tract. In the follicular phase, rising oestrogen accelerates gut transit — which can manifest as urgency or looser stools. In the luteal phase, as oestrogen drops and progesterone rises, gut motility slows — producing the bloating, constipation, and "stuck" feeling that many women with PCOS/PMOS report as a chronic baseline. In PCOS/PMOS, where oestrogen dominance and erratic cycle phases are common, this motility dysregulation is amplified and unpredictable.
2. Cortisol and the gut-brain axis
The enteric nervous system — the gut's own neural network — is directly regulated by cortisol via the hypothalamic-pituitary-adrenal (HPA) axis. Elevated cortisol, which is structurally common in PCOS/PMOS, increases intestinal permeability (the mechanism behind "leaky gut"), alters gut microbiome composition, and sensitises visceral pain receptors. This is why stress reliably triggers IBS flares — and why women with PCOS/PMOS, who already have HPA dysregulation, are disproportionately affected. The cortisol-stress connection in PCOS/PMOS covers the HPA axis mechanism in depth.
3. Insulin resistance and gut microbiome diversity
Insulin resistance doesn't just affect glucose regulation — it alters the gut microbiome. Research consistently shows reduced microbial diversity in insulin-resistant individuals, with a relative decrease in Lactobacillus and Bifidobacterium species and an increase in pro-inflammatory gram-negative bacteria. This microbiome shift is independently associated with IBS-type symptoms: bloating, irregular transit, visceral hypersensitivity. In PCOS/PMOS, where insulin resistance affects 50–70% of women regardless of weight, this pathway is active even in those with no formal metabolic diagnosis. How gut microbiome changes show up in your food log explores this connection further.
4. Progesterone resistance and visceral pain
Women with PCOS/PMOS commonly exhibit progesterone resistance — a reduced cellular response to progesterone signalling. Progesterone has a documented inhibitory effect on gut muscle contractions; when this is impaired, the protective slowing of gut transit in the luteal phase becomes unpredictable. Some women experience exaggerated constipation; others experience the opposite — cramping and urgency — because the signal is inconsistent rather than absent. This is the mechanism behind the "PCOS gut that doesn't behave like a normal cycle."
What your Atlas check-in data is telling you
Five signals in your daily Atlas data that may be tracking your gut-hormone axis without you realising it:
Bloating or digestive discomfort entries that cluster in the luteal phase (days 15–28)
If you're using the symptom tag or mood/energy fields to note "heavy", "uncomfortable", or low-energy days that coincide with the second half of your cycle, that clustering is a progesterone-motility signal — not random digestive bad luck.
Energy dips that co-occur with high-carb food days, followed by digestive symptoms the next morning
Reactive hypoglycaemia from high-GI meals spikes cortisol. The cortisol spike activates the gut-brain axis. The gut-brain axis response (increased motility or visceral pain) arrives 8–12 hours later. Your food log can reveal this chain — if you're looking for it.
Cravings for sugar or refined carbs immediately after a low-mood or high-stress day
The gut-brain axis runs in both directions. Gut microbiome dysbiosis drives cravings for the foods (simple sugars) that feed the pro-inflammatory bacterial strains causing the dysbiosis. Your cravings log isn't just a willpower readout — it's a microbiome signal.
Mood dips that precede digestive symptoms by 24–48 hours
Serotonin is produced primarily in the gut (approximately 90%). When gut inflammation or motility disruption reduces serotonin synthesis, mood decline often precedes the obvious GI symptoms by a day or two. A mood dip that "comes from nowhere" and is followed by a digestive difficult day is not random — it's the gut-brain axis running its timeline.
Symptom improvement on weeks with consistent sleep (7+ hours, low variability)
Sleep is one of the strongest regulators of cortisol rhythm. When sleep is consistent, the cortisol awakening response is appropriate — which normalises gut motility signalling. If your best gut weeks in your check-in data consistently overlap with your best sleep weeks, that's the HPA-gut axis being regulated from the top down. The sleep-cortisol connection in PCOS/PMOS explains why consistent sleep is one of the highest-leverage interventions for this pattern.
> "Most women with PCOS/PMOS who also have IBS have been managing two conditions simultaneously without knowing it. Your tracking data sees the overlap — even when no one has named it yet."
Three patterns worth tracking over 14+ days
1. Cycle phase vs. digestive symptom frequency
Log a simple flag on days you experience bloating, cramping, urgency, or constipation. After 6–8 weeks, map these against your cycle day data. If they cluster in the luteal phase (days 15–28), that's the oestrogen-progesterone motility mechanism. If they're randomly distributed, cortisol dysregulation or microbiome factors are more likely the primary driver.
2. Food composition vs. next-morning symptom onset
On evenings where you eat a high-carb or high-GI meal, flag the morning after. After 4 weeks, calculate what percentage of "difficult mornings" were preceded by high-carb evenings vs. protein-dominant evenings. A consistent gap (>30% difference) is actionable data for a dietary experiment.
3. Sleep consistency vs. weekly gut symptom count
Count your "bad gut" days per week. Overlay this with your sleep quality scores from the same weeks. A correlation of 0.6 or higher between poor sleep weeks and high gut-symptom weeks is a strong signal that the HPA-gut pathway is your primary mechanism — and that sleep intervention (not just dietary adjustment) is the higher-leverage move.
Atlas Premium surfaces pattern engine cards across all three of these overlays once you have 7+ days of data in each dimension.
What to do with the insight
Run a 4-week low-GI experiment, tracked
Swap high-GI foods (white bread, white rice, processed cereals) for low-GI equivalents (oats, lentils, sweet potato, brown rice) for 28 days. Log your gut symptom days in Atlas throughout. The goal isn't a permanent dietary overhaul — it's to establish whether the insulin-microbiome pathway is your primary mechanism. If gut symptom days drop by 40%+, it's the insulin axis. If they don't change, look at the cortisol/stress pathway instead.
Test a prebiotic or fermented food for 30 days, logging throughout
Add one prebiotic food daily (garlic, onion, leeks, asparagus, or chicory root) or one fermented food (kefir, kimchi, sauerkraut) and log it as a habit tag. After 30 days, compare gut symptom frequency to the 30 days before. This is a crude gut microbiome signal — but it's better than guessing, and it creates data your GP can interpret. Tracking your gut microbiome response through your food log covers how to make this data legible.
GP framing: bring your phase-symptom data
When presenting IBS that may be hormonally driven, the most useful clinical framing is: "My gut symptoms follow a clear cycle-phase pattern — they're consistently worse in the second half of my cycle and improve in the follicular phase. I'd like to explore whether oestrogen/progesterone dysregulation is a primary factor, and whether a gut microbiome test or low-FODMAP trial is appropriate alongside addressing my PCOS/PMOS insulin resistance." This framing opens both the gastroenterology and endocrinology channels simultaneously, rather than allowing IBS and PCOS/PMOS to be managed in isolation — which is how most women end up bouncing between specialties without a joined-up plan. How inflammation shows up in your daily tracking data is also useful context for that GP conversation.
If you've spent years managing "unpredictable digestion" and "hormonal chaos" as two separate problems, your tracking data may be about to show you they're the same system.